Z-1390-2016 Class III Terminated
FDA device recall Z-1390-2016 was initiated by Becton, Dickinson And Company, BD Biosciences on Mar 18, 2016 and is designated Class III. Reason for recall: The carton label for one lot of BD Retic-Count Reticulocyte Reagent System had the incorrect storage conditions. The labels on the reagent as well as the Instructions for Use are correct. The recall status is terminated (terminated Dec 2, 2016). Affected quantity: 205.
Recall details
- Product Type
- Devices
- Report Date
- Apr 20, 2016
- Initiation Date
- Mar 18, 2016
- Termination Date
- Dec 2, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 205
Product description
BD-Retic-Count Reticulocyte Reagent System; Hematology: Used for in vitro diagnostics
Reason for recall
The carton label for one lot of BD Retic-Count Reticulocyte Reagent System had the incorrect storage conditions. The labels on the reagent as well as the Instructions for Use are correct.
Distribution pattern
Worldwide Distribution - US Distribution to the states of : CT, MN, FL, NY, CA, MA, DC, UT, VA and IN., and to the countries of : Belgium, Brazil, Canada, China, India, Japan, Korea, Singapore and Taiwan.
Code information
Product number 349214, Lot number 5175559, Expiry 5/31/16.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1390-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026